In a pediatric patient with a rash on the posterior thighs who has recent respiratory syncytial virus (RSV) infection and has already received the varicella (chicken‑pox) vaccine, what is the likely diagnosis and recommended management?

Breakthrough Varicella (Chickenpox) Despite Vaccination

This is most likely breakthrough varicella infection, and you should treat it as chickenpox even though the child has been vaccinated. The combination of a rash on the posterior legs following recent RSV infection in a vaccinated child is consistent with breakthrough varicella, which can occur in 15-28% of vaccine recipients and may be triggered by concurrent viral illness 1.

Why This Is Breakthrough Varicella

The clinical scenario fits the established pattern of breakthrough disease:

• Vaccination does not provide 100% protection: Single-dose varicella vaccine has only 80-85% effectiveness for preventing disease of any severity 1. Approximately 15% of vaccine recipients have no or partial response to one dose 1.

• RSV as a potential trigger: Recent research demonstrates that respiratory viruses including RSV can be associated with atypical viral exanthems in pediatric patients 2. While the mechanism isn't fully established, concurrent viral infections may unmask susceptibility or trigger reactivation.

• Location matters less than characteristics: While breakthrough varicella typically presents with fewer lesions (median <50 vs 250-500 in unvaccinated children), approximately 25% of breakthrough cases can present with >50 lesions similar to wild-type infection 1.

Key Diagnostic Features to Confirm

Look for these specific characteristics that distinguish breakthrough varicella:

• Lesion appearance: Vesicular lesions in various stages of evolution (macules → papules → vesicles → crusts)
• Distribution: May be more localized than classic varicella, but can still be generalized 3
• Timing: Peak occurrence 5-26 days post-exposure or during concurrent viral illness 4
• Pruritus: Usually present, though may be less intense than wild-type varicella
• Fever: Often lower grade or absent compared to unvaccinated cases 1

Critical Management Steps

1. Confirm the diagnosis clinically - PCR testing is available but not always necessary for typical presentations. The rash characteristics and vaccination history are usually sufficient.

2. Implement immediate infection control:

• Isolate the patient until all lesions are crusted (typically 5-7 days) 1
• The child is contagious and can transmit vaccine-strain or wild-type virus to susceptible contacts 4
• Identify and protect high-risk contacts: immunocompromised individuals, pregnant women without immunity, and newborns 4

3. Avoid salicylates (aspirin) for 6 weeks due to Reye syndrome risk 4

4. Provide symptomatic treatment:

• Antihistamines for pruritus
• Acetaminophen (NOT aspirin) for fever if needed
• Keep nails trimmed to prevent secondary bacterial infection

5. Monitor for complications: While breakthrough varicella is typically milder, bacterial superinfection (cellulitis, impetigo) can still occur 3. Watch for increasing erythema, warmth, or purulent drainage.

Common Pitfalls to Avoid

• Don't dismiss varicella in vaccinated children: Breakthrough disease is well-documented and can be clinically significant 3. The two-dose schedule was implemented specifically because single-dose protection was insufficient 1.

• Don't assume it's a drug reaction or other viral exanthem: While RSV can cause atypical rashes 2, a vesicular rash in a child with recent viral illness and varicella vaccination history is breakthrough varicella until proven otherwise.

• Don't forget school/daycare exclusion: Even mild breakthrough cases are contagious and require exclusion for 3-5 days or until all lesions are crusted 1.

Prevention Going Forward

Ensure the child receives a second dose of varicella vaccine (if not already given). The two-dose regimen provides 98% effectiveness versus 94% for one dose, with 100% efficacy against severe disease 1. The second dose should be given at least 3 months after the first (or 28 days minimum if inadvertently given earlier) 1.

This case underscores why the AAP and CDC moved to a two-dose varicella vaccination schedule in 2007 - single-dose protection was insufficient to prevent outbreaks and breakthrough disease in school-aged children 1.